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are deemed to be synonymous for the pur-
poses of the provisions of law regarding 
the Ii censure and regulation of optometry. 
[S. B&PJ 
SB 921 (Maddy), as introduced March 
4, would provide that it is unprofessional 
conduct for an optometrist to fail to advise 
a patient in writing of any pathology that 
requires the attention of a physician when 
an examination of the eyes indicates a 
substantial likelihood of any pathology. 
[S. B&PJ 
SB 842 (Presley), as amended April 
13, would authorize the Board to issue 
interim orders of suspension and other 
license restrictions, as specified, against 
its licensees. [A. CPGE&EDJ 
■ LITIGATION 
In California Optometric Association 
(COA) v. Division of Allied Health Pro-
fessions, Medical Board of California, 
No. 531542 (filed January 11 in Sacra-
mento County Superior Court), and Engi-
neers and Scientists of California (ESC), 
et al. v. Division of Allied Health Profes-
sions, Medical Board of California, No. 
706751-0 (filed October 8, 1992 in Ala-
meda County Superior Court), COA and 
ESC challenge the validity of DAHP's 
medical assistant regulations. 
Following the enactment of SB 645 
(Royce) (Chapter 666, Statutes of 1988), 
it took DAHP over three years to adopt 
section 1366, Title 16 of the CCR, its 
regulation defining the technical support 
services which unlicensed medical assis-
tants (MAs) may perform and establishing 
standards for appropriate MA training and 
supervision. During the lengthy rulemak-
ing process, DCA rejected DAHP's pro-
posed regulations twice and the Office of 
Administrative Law rejected them once 
before finally approving them in March 
1992. 
During the rulemaking hearings, COA 
and the Board of Optometry objected to 
language in the proposed regulations stat-
ing that MAs are permitted to perform 
"automated visual field testing, tonome-
try, or other simple or automated ophthal-
mic testing not requiring interpretation in 
order to obtain test results, using machines 
or instruments, but are precluded from the 
exercise of any judgment or interpretation 
of the data obtained on the part of the 
operator." [ 12: 1 CRLR 88-89 J However, 
DAHP overruled the objections and in-
cluded this language in its final regula-
tions. COA and ESC claim that section 
1366 is invalid because the conduct au-
thorized is beyond the scope of DAHP's 
authority and conflicts with DAHP's en-
abling statutes; further, it conflicts with 
Business and Professions Code sections 
100 
3040 and 3041 (which define the practice 
of optometry and prohibit unlicensed per-
sons from engaging in optometry). At this 
writing, the Attorney General has filed an 
answer on behalf of DAHP; no court hear-
ing has been set. 
■ RECENT MEETINGS 
At the February 18 meeting, Executive 
Officer Karen Ollinger reviewed pre-
viously-approved budget changes, and re-
ported that the Board is close to covering 
its costs. Ollinger also announced that the 
occupational analysis by Human Resource 
Strategies is proceeding on schedule. 
[ 13: 1 CRLR 59 J Finally, Board President 
Thomas Nagy, OD, announced that Board 
member Stephen R. Chun, OD, was 
named Optometrist of the Year at the an-
nual California Optometric Association 
Congress. 
■ FUTURE MEETINGS 
November 17-18 in Orange County. 
BOARD OF PHARMACY 
Executive Officer: Patricia Harris 
(916) 445-5014 
Pursuant to Business and Professions Code section 4000 et seq., the Board 
of Pharmacy grants licenses and permits 
to pharmacists, pharmacies, drug manu-
facturers, wholesalers and sellers of hypo-
dermic needles. It regulates all sales of 
dangerous drugs, controlled substances 
and poisons. The Board is authorized to 
adopt regulations, which are codified in 
Division 17, Title 16 of the California 
Code of Regulations (CCR). To enforce its 
regulations, the Board employs full-time 
inspectors who investigate accusations 
and complaints received by the Board. 
Investigations may be conducted openly 
or covertly as the situation demands. 
The Board conducts fact-finding and 
disciplinary hearings and is authorized by 
law to suspend or revoke licenses or per-
mits for a variety of reasons, including 
professional misconduct and any acts sub-
stantially related to the practice of phar-
macy. 
The Board consists of ten members, 
three of whom are public. The remaining 
members are pharmacists, five of whom 
must be active practitioners. All are ap-
pointed for four-year terms. 
■ MAJOR PROJECTS 
Restructuring the Enforcement 
Unit. As the Board has not augmented its 
enforcement program in at least ten years, 
it spent considerable time at its October 
1992 meeting discussing the need to ex-
pand the program in light of the increasing 
number of pharmacies and licensed phar-
macists in California, the establishment of 
new registration programs such as medi-
cal device retailers and pharmacy techni-
cians, and changes in the law governing 
the practice of pharmacy. [ 13: 1 CRLR 60] 
At the Board's April 28-29 meeting, 
Executive Officer Patricia Harris reported 
that the Governor and the budget subcom-
mittees in both houses of the legislature 
have tentatively approved a $703,000 in-
crease to the Board's 1993-94 budget to 
establish eight additional enforcement 
unit positions: five inspectors, one super-
vising inspector, one consumer services 
representative, and one office technician. 
The increase in staff will enable the Board 
to establish a public assistance unit staffed 
by complaint handlers to assist consumers 
who call with questions regarding phar-
macy services and pharmacists; com-
plaints would be opened by this unit and 
referred to the inspection staff for investi-
gation. This process is expected to enable 
Board inspectors to focus their efforts on 
inspection, not compiaint processing. 
Harris cautioned that the full legislature 
has yet to pass the Governor's budget, and 
that the budget augmentation may be re-
vised or deleted. 
Board Discusses Request for Regu-
latory Change. At its January 20-21 
meeting, the Board noted that it had re-
ceived several requests to revise section 
1719(c), Title 16 of the CCR, which pro-
vides that, as of April 16, 1992, all candi-
dates for the pharmacist licensure exami-
nation who are graduates of a foreign 
pharmacy school (any school located out-
side the United States) must demonstrate 
proficiency in English by achieving a 
score of at least 220 on the Test of Spoken 
English administered by the Educational 
Testing Service. Board member Gilbert 
Castillo noted that the issue was originally 
discussed by the Board and referred to its 
Competency Committee for evaluation; 
the Committee held preliminary hearings 
and invited public input. Following dis-
cussion, the Board unanimously agreed 
that it is in the best interest of the con-
sumer to continue to require that foreign 
pharmacy graduates pass the Test of Spo-
ken English. 
Board Considers Electronic Trans-
mission of Prescriptions. At the Board's 
January 20-21 meeting, the Board's Com-
mittee on Electronic Transmission and 
Faxing of Prescriptions recommended 
that the Board pursue statutory and regu-
latory changes to allow for the electronic 
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transmission of prescriptions. Under the 
Committee's proposal, the term "elec-
tronic transmission prescription" would 
include both electronic image transmis-
sion prescriptions (any prescription order 
for which a facsimile of the order is re-
ceived by a pharmacy from a licensed 
prescriber) and electronic data transmis-
sion prescriptions (any prescription order, 
other than an electronic image transmis-
sion prescription, which is electronically 
transmitted from a licensed prescriber to a 
pharmacy). Under the proposal, if a pre-
scription is electronically transmitted to a 
pharmacy, the pharmacy must maintain a 
hard copy. Following discussion, the Board 
unanimously agreed to pursue statutory and 
regulatory changes to allow for the elec-
tronic transmission of prescriptions; the pro-
posal was subsequently included in the De-
partment of Consumer Affairs' omnibus bill, 
AB 1807 (Bronshvag) (see LEGISLA-
TION). 
Board Considers New Rulemaking 
Proposals. At its January 20-21 and April 
28-29 meetings, the Board discussed a 
proposal to amend section 1732.3, Title 16 
of the CCR, regarding continuing educa-
tion (CE) courses. Among other things, 
section 1732.3 currently provides that a 
recognized CE provider's coursework 
shall be valid for two years following the 
initial Board approval; the Board is con-
sidering amending this section to provide 
that such coursework would be valid for 
up to three years following Board ap-
proval. This modification was suggested 
by the Board's Continuing Education 
Committee in recognition of the American 
Council on Pharmaceutical Education's 
policy allowing its approved CE providers 
to use an expiration date of three years for 
some courses. The Board is expected to 
pursue this regulatory change; at this writ-
ing, however, the Board has not published 
notice of its intent to do so in the Califor-
nia Regulatory Notice Register. 
At its April 28-29 meeting, the Board 
discussed the possibility of amending sec-
tion 1717(a), Title 16 of the CCR, which 
specifies that no medication shall be dis-
pensed on prescription except in a new con-
tainer which conforms with standards estab-
lished in the official compendia; section 
1717(a) provides for an exception to the rule 
and designates one type of prescription con-
tainer which may be reused under specific 
conditions, including the condition that the 
container be used for the same drug for the 
same patient. The Board is expected to pur-
sue an amendment to section 1717(a) to 
include an additional type of prescription 
container which may be reused under spe-
cific circumstances; at this writing, however, 
the Board has not published notice of its 
intent to do so in the California Regulatory 
Notice Register. 
Rulemaking Update. The following 
is a status update on rulemaking proposals 
discussed in detail in previous issues of 
the Reporter. 
• Compounding for Prescriber Office 
Use. The Board's adoption of new sec-
tions 1716.1 and 1716.2, Title 16 of the 
CCR, defines the quantity of compounded 
medication which a pharmacist may pro-
vide to a prescriber for office use, and 
specifies the minimum types of records 
that pharmacies must keep when they fur-
nish compounded medication to prescrib-
ers in quantities larger than required for 
the prescriber's immediate office use or 
when a pharmacy compounds medication 
for future furnishing. [ 13: 1 CRLR 61 J 
The Office of Administrative Law 
(OAL) originally disapproved this regula-
tory action in June 1992 on the basis that 
it failed to meet the clarity and necessity 
standards of the Administrative Procedure 
Act. The Board amended its proposal at its 
October 1992 meeting to resolve OAL's 
concerns, and released the modified lan-
guage for a fifteen-day public comment 
period in December. The Board then re-
submitted the proposal to OAL, which 
approved the action on April 7. 
• Medical Device Retailers' Locked 
Storage Requirements. On January 19, 
OAL approved the Board's adoption of 
new section 1748.2, Title 16 of the CCR, 
which provides that a medical device re-
tailer (MDR) may leave a dangerous de-
vice in a retail area of the MDR premises 
during an absence of an exemptee if the 
item is of sufficient size and weight that 
removal from the premises would be dif-
ficult. Any dangerous devices designated 
for display under section 1748.2 shall be 
specifically listed in the written policies 
and procedures of the MDR. [ 13: 1 CRLR 
62] 
However, OAL disapproved th!;! 
Board's proposed adoption of section 
. 17 48.1, Title 16 of the CCR, also regard-
ing MDR locked storage; among other 
things, the original version of section 
1748.1 would have provided that danger-
ous devices shall be furnished from locked 
storage only upon the oral or written au-
thorization of an exemptee to an employee 
of the MDR who operates the service ve-
hicle. OAL found that the Board Jacked 
statutory authority to allow a non-licensed 
person to dispense dangerous devices at 
the direction of an exemptee in this man-
ner. The Board subsequently modified the 
language, released it for a fifteen-day pub-
lic comment period, and resubmitted it to 
OAL; among other things, the modified 
version provides that dangerous devices 
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shall be furnished from locked storage 
only by an exemptee. OAL approved the 
Board's adoption of section 1748.l on 
May 12. 
• Patient Consultation Regulatwns. 
On March 3, OAL approved the Board's 
amendments to sections 1707. l and 
1707 .2, and its adoption of new section 
1707 .3, Title 16 of the CCR, which revise 
the Board's patient consultation require-
ments to comply with federal Omnibus 
Budget Reconciliation Act of 1990 
(OBRA 90) standards. [13:1 CRLR 61] 
However, at its April meeting, the 
Board discussed further amendments to 
section 1707.2. Subsection (a) of section 
1707 .2 requires a pharmacist to provide 
oral consultation to a patient or his/her 
agent, upon request or whenever the phar-
macist deems it warranted. Under subsec-
tion (b), a pharmacist must provide oral 
consultation whenever the prescription 
drug has not previously been dispensed to 
a patient, and whenever a prescription 
drug not previously dispensed to a patient 
in the same dosage, form, strength, or with 
the same written directions is dispensed 
by the pharmacy. Subsection (e) states 
that, notwithstanding the requirements in 
(a) and (b), that a pharmacist is not re-
quired to provide oral consultation when 
a patient or the patient's agent refuses such 
consultation. According to the Depart-
ment of Health Services (DHS), the 
Board's current regulations may not be in 
compliance with OBRA 90, which appar-
ently requires pharmacists to offer an oral 
consultation-an element which the 
Board's regulations lack. Following dis-
cussion, the Board unanimously agreed to 
leave its consultation regulations as they 
are, and to seek clarification from DHS 
and the Health Care Finance Administra-
tion (HCFA) on this issue. 
■ LEGISLATION 
AB 260 (W. Brown), as amended 
April 12, and SB 1048 (Watson), as intro-
duced March 5, would each establish the 
Clean Needle and Syringe Exchange Pilot 
Project, and would authorize pharmacists, 
physicians, and certain other persons to 
furnish hypodermic needles and syringes 
without a prescription or permit as pre-
scribed through the pilot project. [A. 
Floor; S. H&HS] 
AB 667 (Boland). The Pharmacy Law 
regulates the use, sale, and furnishing of 
dangerous drugs and devices, as defined; 
the law prohibits a person from furnishing 
any dangerous device, except upon the 
prescription of a physician, dentist, podi-
atrist, or veterinarian. However, existing 
Jaw provides that this prohibition does not 
apply to the furnishing of any dangerous 
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device by a manufacturer, wholesaler, or 
pharmacy to each other or to a physician, 
dentist, podiatrist, veterinarian, or physi-
cal therapist acting within the scope of 
his/her license under sales and purchase 
records that correctly give the date, the 
names and addresses of the supplier and 
the buyer, the device, and its quantity. As 
amended March 29, this bill would pro-
vide that the prohibition also does not 
apply to the furnishing of any dangerous 
device by a manufacturer, wholesaler, or 
pharmacy to a chiropractor acting within 
the scope of his/her license. 
Existing law authorizes a medical de-
vice retailer to dispense, furnish, transfer, 
or sell a dangerous device only to another 
medical device retailer, a pharmacy, a li-
censed physician, a licensed health care 
facility, a licensed physical therapist, or a 
patient or his/her personal representative. 
This bill would additionally authorize a 
medical device retailer to dispense, fur-
nish, transfer, or sell a dangerous device 
to a licensed chiropractor. [A. Health] 
SB 849 (Bergeson). Under the Phar-
macy Law, a "hospital pharmacy" means 
and includes a pharmacy licensed by the 
Board of Pharmacy and located within any 
hospital, institution, or establishment that 
maintains and operates organized inpa-
tient facilities for the diagnosis, care, and 
treatment of human illnesses in accor-
dance with certain requirements. As 
amended April 26, this bill would instead 
define a "hospital pharmacy" to mean a 
pharmacy licensed by the Board and lo-
cated within a general acute care hospital, 
as defined, acute psychiatric hospital, as 
defined, or a special hospital, as defined 
in accordance with certain requirements. 
[S. B&PJ 
SB 842 (Presley), as amended April 
13, would permit the Board to issue in-
terim orders of suspension and other li-
cense restrictions, as specified, against its 
licensees. [A. CPGE&EDJ 
AB 1807 (Bronshvag), as amended 
May 3, would require a pharmacy, except 
a nonresident pharmacy, that ships or 
mails prescriptions to residents of Califor-
nia to provide certain toll-free telephone 
service, and written notification of the 
availability of that service to patients. 
Existing law defines the term "pre-
scription" for the purposes of existing law 
relating to licensure of pharmacists, regu-
lation of pharmacies, and regulation of 
controlled substances. This bill would re-
vise the definition, for these purposes, to 
include electronically transmitted pre-
scriptions, as defined. 
Under existing law, it is a misdemea-
nor for any person to falsely represent 
himself/herself to be a person who can 
102 
lawfully prescribe a drug, or to falsely 
represent that he/she is acting on behalf of 
a person who can lawfully prescribe a 
drug, in a telephone communication with 
a registered pharmacist. This bill would 
also make it a misdemeanor to make these 
false representations by electronic com-
munication. [A. W&MJ 
AB 2099 (Epple). The Pharmacy Law 
prohibits a pharmacist from dispensing 
any prescription except in a container cor-
rectly labeled with certain types of infor-
mation. As amended April 28, this bill 
would additionally require the container 
label to identify the condition for which 
the drug was prescribed if the patient re-
quests it and the prescription identifies the 
condition. [A. W&MJ 
AB 2155 (Polanco). Existing law re-
quires prescription blanks in triplicate to 
be issued by the Department of Justice and 
furnished to any practitioner authorized to 
write a prescription for Schedule II con-
trolled substances. Existing law prohibits 
the Department of Justice from issuing 
more than l 00 triplicate prescription 
blanks to any authorized practitioner. As 
introduced March 5, this bill would estab-
lish the Medical and Pharmacy Ad Hoc 
Committee within the Department of Con-
sumer Affairs, and require it to study all 
matters regarding the Department of 
Justice's ongoing monitoring and over-
sight activities of prescriptions for Sched-
ule II controlled substances and advise the 
Attorney General on these matters. It 
would require the Committee membership 
to consist of a pharmacist and various 
persons who are engaged in prescribed 
specialties of medical practice. [A. W&MJ 
SB 432 (Greene). Existing law generally 
requires every prescription for a controlled 
substance classified in Schedule II to be in 
writing. One exception to this general re-
quirement is when failure to issue a prescrip-
tion for a controlled substance classified in 
Schedule II to a patient in a licensed skilled 
nursing facility, an intermediate care facility, 
or a licensed home health agency providing 
hospice care would, in the opinion of the 
prescriber, present an immediate hazard to 
the patient's health and welfare or result in 
intense pain and suffering to the patient; 
under the circumstances, the prescription 
may be dispensed upon an oral prescription. 
As amended May 19, this bill would instead 
provide that any order for a Schedule II 
controlled substance in a licensed skilled 
nursing facility, intermediate health care fa-
cility, or a licensed home health agency pro-
viding hospice care may be dispensed upon 
an oral prescription. [S. Jud] 
SB 1051 (McCorquodale). The Phar-
macy Law requires a pharmacist to inform 
a patient orally or in writing of the harmful 
effects of a drug dispensed by prescription , 
if the drug poses a substantial risk to the 
person consuming the drug when taken in 
combination with alcohol or if the drug 
may impair a person's ability to drive a 
motor vehicle, whichever is applicable, 
and the Board determines that the drug 
requires the warning. The Pharmacy Law 
requires any pharmacy located outside 
California that ships, mails, or delivers 
any controlled substances or dangerous 
drugs or devices into this state pursuant to 
a prescription to register with the Board, 
disclose information regarding the phar-
macy to the Board, and meet other condi-
tions. Under the Pharmacy Law, one of 
those conditions is the requirement that 
the pharmacy, within a prescribed time 
period, provide toll-free telephone service 
to facilitate communication between pa-
tients in California and a pharmacist at the 
pharmacy who has access to the patient's 
records. It also requires the toll-free num-
ber to be disclosed on a label affixed to 
each container of drugs dispensed to pa-
tients in this state. As amended April 21, 
this bill would require the Board to adopt 
regulations that apply the same require-
ments or standards for oral consultation 
between the pharmacy and the patient, 
under certain circumstances, to a nonresi-
dent pharmacy as are applicable to a phar-
macy that has been issued a permit by the 
Board. [S. Appr] 
SB 1153 (Watson). Existing law pro-
vides for the Medi-Cal program adminis-
tered by DHS, pursuant to which medical 
benefits, including certain prescription 
drugs, are provided to public assistance 
recipients and certain other low-income 
persons. As amended April 28, this bill 
would establish the Drug Utilization Re-
view Board to review, evaluate, and make 
recommendations to DHS on retrospec-
tive drug utilization reviews, standards ap-
plications, educational interventions, and 
drug utilization program profile develop-
ment. This bill would also require the 
Board of Pharmacy, with the advice of the 
Drug Utilization Review Board, to adopt 
and publish guidelines and standards to be 
used by pharmacists in their counseling of 
Medi-Cal recipients. [S. Appr] 
AB 2020 (Isenberg), as amended May 
18, would, among other things, authorize 
optometrists to use, prescribe, and dis-
pense specified pharmaceutical com-
pounds to a patient. This bill would also 
make it a misdemeanor for any person 
licensed as an optometrist to refer a patient 
to a pharmacy that is owned by that licen-
see or in which the licensee has propri-
etary interest. [A. Floor] 
SB 1136 (Kelley). Under the Medi-Cal 
program administered by DHS, pharma-
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cists are reimbursed for covered drugs 
based on prices determined by the Depart-
ment; existing law authorizes pharmacists 
to select a generic drug type, as defined, 
over a name brand drug product when 
filling a prescription, unless the prescriber 
specifies otherwise. As amended May 5, 
this bill would require that a generically 
substitutable product shall not be reim-
bursable if the DHS Director determines 
that a product from a company subject to 
rebates as an innovator company under 
federal law is lower in net cost to the state 
than a generically substitutable product 
not subject to the rebates; it would require 
the Director to notify pharmacists of these 
determinations. [S. Appr] 
■ LITIGATION 
Plaintiffs are appealing the trial court's 
ruling in Californians for Safe Prescrip-
tions v. California State Board of Phar-
macy, No. BS019433 (Dec. 15, 1992), 
which held that the Board followed and 
complied with the Administrative Proce-
dure Act in promulgating and adopting its 
pharmacy technician regulations. [ 13:1 
CRLR 62] Plaintiffs, members of a non-
profit organization consisting of approxi-
mately 5,000 licensed pharmacists, filed a 
notice of appeal on January 5; at this writ-
ing, no date for oral argument has been set. 
On February 18, the California Su-
preme Court granted the pharmacy's peti-
tion for review of the Fifth District Court 
of Appeal's decision in Huggins v. Longs 
Drug Stores California, Inc., No. 
F016033 (Dec. 4, 1992). The appellate 
court held that a pharmacist's provision of 
incorrect dosage amounts for a prescrip-
tion which the pharmacist knew or should 
have known would be administered to an 
infant by the infant's parents constitutes 
negligent action directed at the parent car-
egivers, which may allow the caregivers 
to recover damages for negligent inflic-
tion of emotional distress. [ 13: 1 CRLR 
63] 
■ RECENT MEETINGS 
At the Board's January 20-21 meeting, 
the Board considered its Long-Term Care 
Committee's recommendation that it adopt 
proposed standards for pharmacies servic-
ing long-term care facilities. Among other 
things, the standards state the obligations of 
pharmacies servicing such facilities, which 
include establishing procedures for obtain-
ing and providing necessary drugs on a 
timely manner, including on a 24-hour basis, 
and for the availability of emergency drug 
supplies, in conformity with federal and 
state laws and regulations, and maintaining 
drug information services available to facil-
ity nursing staff, prescribers, other physi-
cians, and the facility's consultant phar-
macist. Following discussion, the Board 
unanimously adopted the standards. 
■ FUTURE MEETINGS 







Harold L. Turner 
(916) 263-2222 
The Board of Registration for Profes-sional Engineers and Land Surveyors 
(PELS) regulates the practice of engineer-
ing and land surveying through its admin-
istration of the Professional Engineers 
Act, sections 6700 through 6799 of the 
Business and Professions Code, and the 
Professional Land Surveyors' Act, sec-
tions 8700 through 8805 of the Business 
and Professions Code. The Board's regu-
lations are found in Division 5, Title 16 of 
the California Code of Regulations 
(CCR). 
The basic functions of the Board are to 
conduct examinations, issue certificates, 
registrations, and/or licenses, and appro-
priately channel complaints against regis-
trants/licensees. The Board is additionally 
empowered to suspend or revoke registra-
tions/licenses. The Board considers the 
proposed decisions of administrative law 
judges who hear appeals of applicants 
who are denied a registration/license, and 
those who have had their registration/li-
cense suspended or revoked for viola-
tions. 
The Board consists of thirteen mem-
bers: seven public members, one licensed 
land surveyor, four registered Practice Act 
engineers and one Title Act engineer. 
Eleven of the members are appointed by 
the Governor for four-year terms which 
expire on a staggered basis. One public 
member is appointed by the Speaker of the 
Assembly and one by the Senate Rules 
Committee. 
The Board has established four stand-
ing committees and appoints other special 
committees as needed. The four standing 
committees are Administration, Enforce-
ment, Examination/Qualifications, and 
Legislation. The committees function in 
an advisory capacity unless specifically 
authorized to make binding decisions by 
the Board. 
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Professional engineers are registered 
through the three Practice Act categories 
of civil, electrical, and mechanical engi-
neering under section 6730 of the Busi-
ness and Professions Code. The Title Act 
categories of agricultural, chemical, con-
trol system, corrosion, fire protection, in-
dustrial, manufacturing, metallurgical, 
nuclear, petroleum, quality, safety, and 
traffic engineering are registered under 
section 6732 of the Business and Profes-
sions Code. 
Structural engineering and geotechni-
cal engineering are authorities linked to 
the civil Practice Act and require an addi-
tional examination after qualification as a 
civil engineer. 
At its January 29 meeting, PELS se-
lected Harold L. Turner as its new Execu-
tive Officer; Turner, formerly California's 
Deputy Auditor General, was hired to re-
place Darlene Stroup, who resigned in 
August 1992. [13:1 CRLR 64] In Febru-
ary, Governor Wilson announced the ap-
pointment of Stephen H. Lazarian as 
PELS' new public member; Lazarian is a 
self-employed attorney from Pasadena 
who formerly served on the Contractors 
State License Board from 1985-92 and 
was its chair from 1988-89. 
■ MAJOR PROJECTS 
Proposed Elimination of Title Act 
Protection for Traffic Engineers. At its 
March 12 meeting, PELS discussed the 
possible elimination of Title Act coverage 
for traffic engineering. The proposed ac-
tion is opposed by S.E. Rowe, General 
Manager of the City of Los Angeles' De-
partment of Transportation, who contends 
that title protection for traffic engineering 
is necessary primarily because of its "ex-
treme implications in saving lives and re-
ducing injuries and property damage to 
the public." If protection is eliminated, 
Rowe contends that a registered civil en-
gineer with little or no experience in traffic 
engineering could make traffic recom-
mendations on behalf of his/her clients. 
Department of Consumer Affairs (DCA) 
legal counsel Don Chang noted that prep-
aration of certain traffic mitigation or 
worksite traffic control plans does not 
constitute the practice of civil engineer-
ing. Board President Larry Dolson re-
ferred the matter to a special committee to 
further consider the scope of Title Act 
coverage. 
At PELS' April 23 meeting, Board 
member Ted Fairfield reported that, based 
on a review of current National Council of 
Examiners for Engineering and Surveying 
(NCEES) test questions and most college 
curricula, there appear to be inconsisten-
cies between the definition and educa-
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